PBS, 25% Glycerol, 1% BSA, 0.3% Proclin 300
| 应用 | 稀释度 | 推荐种属 |
|---|---|---|
| FCM | 5μl per million cells in 100μl volume | Ms |
TGF-β1 (Transforming Growth Factor-beta 1) is a multifunctional cytokine belonging to the TGF-β superfamily, playing a pivotal role in cell proliferation, differentiation, apoptosis, immune regulation, extracellular matrix formation, and tissue repair. Synthesized as an inactive precursor, it undergoes proteolytic activation to form a biologically active homodimer. TGF-β1 signals through binding to TGF-β receptors (Type I/II), triggering both Smad-dependent (canonical) and Smad-independent (non-canonical, e.g., MAPK, PI3K) pathways. Critical in embryogenesis, wound healing, and fibrosis, TGF-β1 exhibits dual roles in disease—acting as a tumor suppressor early in cancer but promoting metastasis in advanced stages. Dysregulation is linked to fibrotic disorders (e.g., pulmonary fibrosis), autoimmune diseases, and cancer progression. Its context-dependent functions (anti-inflammatory vs. pro-fibrotic/tumorigenic) are influenced by microenvironmental cues, making it a therapeutic target for fibrosis, cancer, and inflammatory conditions.
Flow cytometric analysis of Mouse LAP (TGF-β1) expression on C57BL/6 mouse splenocytes. C57BL/6 mouse blood cells were stained with SDT FITC Rat Anti-Mouse CD41 Antibody (S0B5205) at 5 μl/test and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Left panel) or SDT Alexa Fluor® 647 Mouse Anti-Mouse LAP (TGF-β1) Antibody (Right panel) at 5 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
您现在的位置：